NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-CA-20-107 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-CA-20-046 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to advance our understanding of: the modes of transmission of Kaposi sarcoma-associated herpesvirus (KSHV), also called human herpesvirus-8 (HHV-8); the biology of the initial steps of infection; and the risk factors for infection. Such studies should inform and advance efforts to reduce or eliminate KSHV transmission and thus prevent Kaposi sarcoma (KS), KSHV-associated multicentric Castleman disease (MCD), primary effusion lymphoma (PEL), and other KSHV-induced diseases in populations living with HIV or at high risk of developing HIV infection.
Notice NOT-HS-20-017 from the NIH Guide for Grants and Contracts
Notice NOT-AG-20-043 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DC-20-002 from the NIH Guide for Grants and Contracts. The purpose of this program is to recruit and retain outstanding, postdoctoral-level health professionals who have demonstrated potential and interest in pursuing careers as clinician-investigators. To address the growing need for this critical component of the research workforce, this funding opportunity seeks applications from institutional programs that can provide outstanding mentored research opportunities to medical students and resident-investigators in otolaryngology and foster their ability to transition to individual career development research awards. The program will support institutions to create a pathway in otolaryngology research training through structured programs for clinician-investigators with defined program milestones.
Notice NOT-AA-20-021 from the NIH Guide for Grants and Contracts
Notice NOT-OD-20-175 from the NIH Guide for Grants and Contracts
Notice NOT-AI-20-075 from the NIH Guide for Grants and Contracts
Notice NOT-CA-20-106 from the NIH Guide for Grants and Contracts
Notice NOT-AI-20-074 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-ES-20-007 from the NIH Guide for Grants and Contracts. The goal of the Pediatric and Reproductive Environmental Health Scholars (PREHS) program is to create of a strong network of healthcare professionals who possess the skills and knowledge to address the complexities of pediatric and reproductive environmental health. The PREHS program is envisioned as a strategy to bridge clinical training with a career in environmental health research relevant to pediatrics and reproductive health. As such, the PREHS program will provide training in clinical practice in environmental health, community-level advocacy, and teaching to pediatric healthcare providers, obstetricians/gynecologists, nurses, and other interested healthcare professionals, to be known as PREH Scholars. These K12 grant awards will generate well-qualified pediatric and reproductive environmental health leaders.
Funding Opportunity RFA-DK-20-509 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites one application from the Program Director(s)/Principal Investigator(s) of the current Integrated Islet Distribution Program (IIDP) to renew the program andmaintain support for its continuing mission to provide the scientific community with important islet resources for diabetes research.The IIDP facilitates the distribution of human islets to biomedical researchers byestablishing partnerships with qualified islet isolation facilities to prepare and distribute human islets. The programmanages an application process to establish investigator eligibility to receive islet shipments, informs investigators of islet availability, manages a cost recovery system through fees collected from islet recipients, and oversees standardized phenotypic and genotypic analyses of islet preparations distributed throughout theIIDP network. Human islets remain an essential resource for diabetes research to advance our understanding of human islet cell biology, and to promote the development of new therapiesfor the prevention and treatment of diabetes.
Notice NOT-EB-20-019 from the NIH Guide for Grants and Contracts
Notice NOT-AG-20-050 from the NIH Guide for Grants and Contracts
Notice NOT-OH-20-013 from the NIH Guide for Grants and Contracts
Notice NOT-OH-21-001 from the NIH Guide for Grants and Contracts
Notice NOT-OH-21-002 from the NIH Guide for Grants and Contracts
Notice NOT-OH-21-003 from the NIH Guide for Grants and Contracts
Notice NOT-HD-20-033 from the NIH Guide for Grants and Contracts
Notice NOT-HD-20-029 from the NIH Guide for Grants and Contracts